Diagnostic Accuracy of Point-of-Care Fecal Calprotectin and Immunochemical Occult Blood Tests for Diagnosis of Organic Bowel Disease in Primary Care: The Cost-Effectiveness of a Decision Rule for Abdominal Complaints in Primary Care (CEDAR) Study | Zendy

Liselotte Kok | Zendy; Sjoerd G. Elias | Zendy; Ben J.�M. Witteman | Zendy; Jelle G. Goedhard | Zendy; Jean Muris | Zendy; Karel G.M. Moons | Zendy; Niek J. de Wit | Zendy

Open Access

Diagnostic Accuracy of Point-of-Care Fecal Calprotectin and Immunochemical Occult Blood Tests for Diagnosis of Organic Bowel Disease in Primary Care: The Cost-Effectiveness of a Decision Rule for Abdominal Complaints in Primary Care (CEDAR) Study

Author(s) -

Liselotte Kok,

Sjoerd G. Elias,

Ben J.�M. Witteman,

Jelle G. Goedhard,

Jean Muris,

Karel G.M. Moons,

Niek J. de Wit

Publication year - 2012

Publication title -

clinical chemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.705

H-Index - 218

eISSN - 1530-8561

pISSN - 0009-9147

DOI - 10.1373/clinchem.2011.177980

Subject(s) - calprotectin , medicine , gastroenterology , fecal occult blood , biomarker , colonoscopy , abdominal pain , feces , inflammatory bowel disease , disease , colorectal cancer , cancer , paleontology , biochemistry , chemistry , biology

Fecal biomarker tests that differentiate between organic bowel disease (OBD) and non-OBD in primary care patients with persistent lower-abdomen complaints could reduce the number of unnecessary referrals for endoscopy. We quantified the accuracy of fecal calprotectin and immunochemical occult blood (iFOBT) point-of-care (POC) tests and a calprotectin ELISA in primary care patients with suspected OBD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research